查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1863445

次世代定序(NGS)套件市场按产品类型、应用、最终用户和定序技术划分－2025 年至 2032 年全球预测

NGS Kits Market by Product Type, Application, End User, Sequencing Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，次世代定序(NGS)套件市场将成长至 39.8 亿美元，复合年增长率为 6.28%。

关键市场统计数据
基准年 2024 24.4亿美元
预计年份：2025年 26亿美元
预测年份 2032 39.8亿美元
复合年增长率 (%) 6.28%

本书权威地介绍了定序套件在科学研究和临床环境中建构稳健的基因组和转录组分析工作流程中所扮演的不断演变的角色。

次世代定序套件是实现高解析度基因组、转录组和表观基因分析的基础工具，广泛应用于科学研究、临床和工业领域。这些套件包含将生物样本转化为定序文库和模板所需的试剂、耗材和预处理流程，其性能特征显着影响下游资料的品质和可解释性。随着定序应用的日益多样化，套件设计也在不断发展，优先考虑灵活性、通量相容性和最少的操作时间，从而支持从标靶定序到全基因组分析等各种实验设计。

在现代实验室环境中，套件供应商面临日益增长的重现性、法规合规性和与自动化平台整合的期望。因此，创新重点在于降低通讯协定的复杂性、提高试剂稳定性以及增强与多种仪器架构的兼容性。同时，终端用户也需要透明的文件和强大的技术支持，以降低采用门槛。本文将定序套件置于整个基因组分析生命週期中进行分析，重点阐述了套件化学性质和工作流程便捷性的逐步改进如何累积累积影响实验结果、采购决策，并促进生命科学价值链上的战略伙伴关係。

了解化学、自动化和平台相容性的整合创新如何重新定义定序套件并重塑基因组学领域的实验室工作流程。

由于化学、奈米孔和基于合成的读通技术的平行发展，以及单细胞和长读长定序应用的日趋成熟，定序套件领域正在经历变革性的变化。传统的定序工作流程着重于逐步提高读长准确性和通量，而近期的进展已将重点转向通用性和端到端工作流程的最佳化。例如，样品製备变得更加模组化，使实验室能够在无需大幅重新开发通讯协定的情况下，客製化输入样本要求和富集策略。同时，模板製备和基于PCR的扩增方法的改进提高了定序结果的均一性并降低了偏差，尤其是在复杂基因组和低起始样本的情况下。

此外，定序平台的演进正迫使套件製造商重新设计其试剂组合和相容性矩阵。新兴的奈米孔化学技术和改进的定序序 (SBS) 方法需要客製化的文库定序套件，以平衡仪器的特定限制和使用者对易用性的期望。这种技术多样性促使套件开发商采用平台无关的设计，或加大与特定仪器生态系统的合作。同时，样本追踪、条码和与生物资讯流程整合的数位化创新，正在改变使用者对试剂套件的期望，使其超越湿实验室性能的范畴，从而形成一个试剂品质、软体互通性和最终用户体验相互融合的竞争格局。

评估近期关税变化对定序套件采购的韧性和供应商策略的影响，以及对营运和供应链的影响。

贸易政策的变化，包括关税调整，对定序套件的采购和分销动态产生重大影响，尤其对于那些跨境采购试剂、耗材和仪器相容配件的企业而言更是如此。关税会改变到岸成本，促使企业重新评估其供应商组合，采用替代物流策略，或将部分生产活动在地化，以维持稳定的供应和可预测的价格。因此，采购团队和业务负责人正在重新评估供应商协议，并探索合约机制以降低上行风险。同时，监管和海关合规团队也在努力简化文件流程，以避免货物延误。

为因应新的关税制度，製造商可能会优先考虑区域性生产投资，或调整分销布局，以维持对临床和研究客户的服务水准。这些策略调整可能导致前置作业时间变化、最低订购量要求调整以及区域售后服务安排变更。重点，关税带来的成本压力将影响整个价值链，促使相关人员简化套件配方、简化包装并优化托盘堆迭以提高运输效率。这些营运奖励凸显了在供应链韧性规划方面开展合作的必要性，以及在贸易政策波动时期与最终用户建立透明沟通管道以管理预期的重要性。

将产品类型、应用需求、最终用户画像和定序技术与策略性套件设计和部署联繫起来的综合細項分析

详细的细分阐明了定序套件生态系统的产品组合和使用者需求。产品类型分为样品製备套件、定序套件和模板製备试剂套件，其中样品製备盒又细分为扩增子特异性套件、RNA定序优化试剂套件和套件定序套件合成定序方法和奈米孔导引化学方法，奈米孔方法本身又分为生物奈米孔试剂和固体相奈米孔试剂。模板製备流程涵盖桥接PCR和乳液PCR两种方法，每种方法都会影响通量和应用范围。

我们基于应用领域的分类阐明了套件如何满足特定的分析目标，涵盖从EXOME和标靶定序到转录组和全基因组分析等应用情境。EXOME通讯协定因临床级和研究级应用而异，标靶策略包括基于杂合反应的富集和PCR驱动的标靶选择。转录组定序包括批量RNA定序和单细胞RNA定序，每种方法对输入处理和扩增精确度都有不同的要求。我们的最终用户细分突出了学术研究机构、临床诊断实验室以及製药和生物技术公司之间操作需求的差异，并进一步强调了这些类别内部的细微差别（例如，政府研究中心与大学实验室、医院诊断机构与独立检测实验室以及新兴生物技术公司与成熟的全球製药公司）。最后，我们的定序技术细分区分了核心平台——奈米孔定序、连接定序和合成定序——并进一步细分了生物奈米孔定序和固体奈米孔定序。这些因素会影响套件化学设计选择和工作流程整合策略。

采用这些细分观点可以明确产品设计、监管合规和服务模式必须如何与应用和最终用户的具体需求保持一致，从而使製造商和经销商能够优先考虑与目标客户群体产生共鸣的产品蓝图和技术支援服务。

区域战略观点：整合美洲、欧洲、中东和非洲以及亚太市场的监管、基础设施和采购现状

在三大关键区域，区域趋势正在塑造定序套件的需求模式、法规要求和供应链结构。在美洲，强大的学术网络和成熟的临床诊断市场推动了对注重合规性、可重复性和与现有仪器基础设施整合的套件的需求。采购流程受到机构采购週期和关键试剂国内生产能力的影响，因此，及时的技术支援和检验的通讯协定是至关重要的采购标准。

欧洲、中东和非洲地区（EMEA）监管环境的多样性和研究基础设施的异质性，既给套件供应商带来了挑战，也带来了机会。协调统一的措施和跨区域临床网络的建​​立，推动了对具备完善文件、多语言技术资源以及本地检验、可适应的工作流程的套件的需求。此外，该地区多个市场正在涌现新兴生物技术中心，加速了先进定序方法的应用，迫使供应商提供灵活的供应安排和在地化的培训计画。

亚太地区基因组研究能力的快速发展和临床定序的日益普及，推动了对可扩展性强、适用于大规模操作、同时兼具成本效益和在不同实验室环境下稳健性的套件的需求。在地化生产措施和政府支持的研发项目进一步鼓励供应商建立区域中心、联合开发伙伴关係和本地化品质体系，以满足监管要求并加快市场准入。总而言之，区域性因素凸显了製定具有地理意识的产品策略和供应链模式的必要性，这些策略和模式需要应对不同的法规环境、基础设施条件和商业性现实。

关键的竞争策略和企业策略将透过产品组合整合、供应链韧性和端到端解决方案交付来决定成败。

在定序套件领域，企业策略越来越取决于其产品组合的广度、技术支援的深度以及提供整合工作流程的能力，从而降低采用门槛。领先的套件开发商优先考虑与多种定序平台的兼容性，同时投资于配方改进，以延长保质期并降低通讯协定的复杂性。与仪器製造商、自动化供应商和生物资讯解决方案供应商建立策略联盟，透过创建满足湿实验室和数据驱动需求的端到端解决方案，进一步提升了价值提案。

除了产品创新之外，竞争优势还来自于供应链的可靠性以及大规模提供检验的通讯协定和培训的能力。那些维护透明的品质系统、提供快速回应的技术服务和清晰文件的公司，更受诊断实验室和大型研究联盟的青睐，因为这些机构将可重复性和法规遵循放在首位。此外，透过将试剂生产与耗材製造和分销相结合来实现垂直整合的公司，可以提供捆绑式解决方案，从而简化采购并支援生命週期管理。最后，专注于模组化套件设计和针对特定应用场景的优化，使公司能够满足各种不同的使用场景，同时最大限度地减少对大量库存SKU的需求，从而实现营运效率和以客户为中心的客製化服务。

为製造商和供应商提供切实可行的策略建议，以加速将定序套件整合到复杂的实验室工作流程中，提高应用率，并增强韧性。

产业领导者可以采取实际行动来巩固市场地位，并应对技术和政策变化。首先，优先考虑供应链多元化，并为关键试剂和耗材建立双重采购管道，可以降低贸易中断的风险。区域製造投资还可以缩短前置作业时间，提高服务应对力。其次，投资于模组化套件架构和自动化平台的标准化接口，可以扩大目标客户群，并降低高通量实验室的整合门槛。

第三，积极与监管机构和临床相关人员合作，开发检验且文件齐全的套件产品，可以加速其在诊断领域的应用，并建立采购决策者的信任。第四，深化与设备和软体合作伙伴的合作，提供检验的端到端工作流程，可以创造超越销售点的强大价值提案。最后，建立完善的售后支援体系，包括实践培训、通讯协定优化服务和快速技术支援，可以提高客户维繫，并使製造商能够透过回馈循环进行迭代创新，从而实现以客户需求主导的产品改进。

我们采用稳健的混合调查方法，结合关键相关人员对话、技术检验和供应链分析，为决策者提供可操作且可靠的见解。

本研究综合运用了多层次的调查方法，结合了与关键相关利益者的直接对话、严谨的二手资料分析和技术检验。初步研究包括对实验室主任、采购负责人、产品经理和法规事务专家进行深入访谈，以收集有关营运重点、挑战和推广驱动因素的第一手资讯。此外，还对技术文献、法规指导文件和产品规格进行了全面审查，以准确了解套件的化学成分、工作流程依赖性和合规性考量，从而补充了这些定性资讯。

为了补充定性研究结果，我们纳入了产品系列映射、专利格局评估和供应链可追溯性分析，以识别通用的製造依赖关係和分销模式。透过将供应商通讯协定的性能声明与独立实验室报告和用户回馈进行交叉核对，实现了技术检验；同时，专家小组的审查为分类和战略意义提供了额外的考虑。在整个调查方法中，我们强调三角验证和透明度，以确保结论反映的是多方面的证据，而非单一来源的断言，从而提出基于实际运作情况的切实可行的建议。

总结观点：明确相关人员在定序套件创新、监管和供应链复杂性方面应重点关注的策略事项

摘要，定序套件在实现高品质基因组和转录组分析方面发挥着至关重要的作用，随着应用领域和平台的日益多元化，其策略重要性也与日俱增。能够根据特定应用需求调整产品设计、投资加强供应链韧性并提供与自动化和资料工作流程检验整合方案的製造商和经销商，将更有利于满足科学研究和临床客户不断变化的需求。鑑于政策和贸易的发展，灵活的筹资策略和透明的沟通对于降低中断风险至关重要。

展望未来，最成功的机构将把套件化学和工作流程的快速创新与对可重复性、法规合规性和上市后支持的不懈追求相结合。这不仅能够解决当前的营运限制，还能使实验室采用更具挑战性的实验设计，并推动科学和临床进步。这个结论凸显了一项策略要务，它应指导整个定序套件生态系统的研发优先排序、商业规划和客户参与。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将自动化微流体和机器人技术整合到NGS套件中，用于高通量临床诊断
  • 采用基于 CRISPR 的靶向序列捕获NGS套件提高罕见突变检测灵敏度
  • 扩展单细胞定序NGS套件，以实现单细胞层级上的同步多体学学分析
  • 推出携带式奈米孔定序NGS套件，用于远端即时基因组监测
  • 开发一种经济高效的多重NGS套件，该试剂盒针对大规模人群基因组筛检进行了最佳化。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章次世代定序(NGS)套件市场（依产品类型划分）

  • 样品製备套件
    • 扩增子库套件
    • RNA-Seq文库建构试剂套件
    • 全基因组文库建构试剂套件
  • 定序套件
    • 奈米孔定序套件
      • 生物奈米孔套件
      • 固态奈米孔套件
    • 合成定序试剂套件
  • 模板准备套件
    • 桥接PCR套件
    • 乳液PCR套件

第九章 依应用分類的次世代定序(NGS)套件市场

  • EXOME定序
    • 临床EXOME定序
    • 研究EXOME定序
  • 标靶定序
    • 基于杂合反应的标靶定序
    • 基于PCR的标靶定序
  • 转录定序
    • 批量RNA测序
    • 单细胞RNA定序
  • 全基因测序

第十章 依最终用户分類的次世代定序(NGS)套件市场

  • 学术研究机构
    • 政府研究所
    • 大学研究所
  • 临床实验室
    • 医院诊断实验室
    • 独立诊断实验室
  • 製药和生物技术公司
    • 生技Start-Ups
    • 全球製药公司

第十一章 依定定序技术分類的次世代定序(NGS)套件市场

  • 奈米孔定序
    • 生物奈米孔
    • 固态奈米孔
  • 连接定序
  • 合成定定序

第十二章 各地区次世代定序（NGS）套件市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章次世代定序(NGS)套件市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国次世代定序（NGS）套件市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • Roche Holding AG
    • Danaher Corporation
    • MGI Tech Co., Ltd.
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Takara Bio Inc.
    • Oxford Nanopore Technologies plc
    • Twist Bioscience Corporation
Product Code: MRR-5C6F41F5AFEA

The NGS Kits Market is projected to grow by USD 3.98 billion at a CAGR of 6.28% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.44 billion
Estimated Year [2025] USD 2.60 billion
Forecast Year [2032] USD 3.98 billion
CAGR (%) 6.28%

An authoritative introduction to the evolving role of sequencing kits in enabling robust genomic and transcriptomic workflows across research and clinical environments

Next-generation sequencing kits are foundational tools that enable high-resolution genomic, transcriptomic and epigenomic analysis across research, clinical and industrial settings. These kits encompass reagents, consumables and preparative workflows that convert biological samples into sequencing-ready libraries and templates, and their performance characteristics materially influence downstream data quality and interpretability. As sequencing applications diversify, kit design has evolved to prioritize flexibility, throughput compatibility and minimized hands-on time, supporting a broader range of experimental designs from targeted panels to whole genome interrogation.

Across contemporary laboratory ecosystems, kit providers face escalating expectations for reproducibility, regulatory readiness and integration with automated platforms. Consequently, innovation has concentrated on reducing protocol complexity, improving reagent stability and enabling compatibility with multiple instrument architectures. At the same time, end users demand transparent documentation and robust technical support to reduce adoption friction. This introduction situates sequencing kits within the broader lifecycle of genomic assays, emphasizing how incremental improvements in kit chemistry and workflow ergonomics cumulatively shape experimental outcomes, influence purchasing decisions and inform strategic partnerships across the life sciences value chain.

How converging innovations in chemistry, automation and platform compatibility are redefining sequencing kits and reshaping laboratory workflows across genomics

The landscape for sequencing kits is undergoing transformative shifts driven by concurrent advances in chemistry, nanopore and synthesis-based readout technologies, and the maturation of single-cell and long-read applications. Historically, sequencing workflows emphasized incremental gains in read accuracy and throughput, but recent progress has pivoted attention toward versatility and end-to-end workflow optimization. For example, library preparation has become more modular, enabling labs to tailor input requirements and enrichment strategies without extensive protocol redevelopment. In parallel, improvements in template preparation and PCR-based amplification approaches have enhanced uniformity and reduced bias, particularly for complex genomes and low-input samples.

Moreover, sequencing platform evolution is prompting kit manufacturers to reimagine reagent sets and compatibility matrices. Emergent nanopore chemistries and enhanced sequencing-by-synthesis formulations require bespoke library and sequencing kits that reconcile instrument-specific constraints with user expectations for ease of use. This technological plurality encourages kit developers to adopt platform-agnostic designs or to invest in tight integration with specific instrument ecosystems. At the same time, digital innovations in sample tracking, barcoding and integration with bioinformatics pipelines are transforming what users expect from a kit beyond wet-lab performance, creating a competitive landscape where reagent quality, software interoperability and end-user experience converge.

Assessing the operational and supply chain consequences of recent tariff shifts and their implications for procurement resilience and supplier strategies in sequencing kits

Trade policy shifts, including tariff adjustments, exert a tangible influence on the procurement and distribution dynamics for sequencing kits, particularly for organizations that source reagents, consumables and instrument-compatible accessories across borders. Tariffs alter landed costs and create incentives for firms to reassess supplier portfolios, adopt alternative logistics strategies, or localize certain manufacturing activities to maintain reliable supply and predictable pricing. As a result, procurement teams and commercial leaders are re-evaluating supplier contracts and exploring contractual mechanisms to mitigate exposure to abrupt cost escalations, while regulatory and customs compliance functions are intensifying documentation practices to avoid shipment delays.

In response to new tariff regimes, manufacturers may prioritize regional manufacturing investments or adjust their distribution footprints to preserve service levels for clinical and research customers. These strategic adjustments can lead to modified lead times, revised minimum order requirements and changes in how after-sales support is structured across territories. Importantly, tariff-driven cost pressures also affect the entire value chain, creating incentives for stakeholders to streamline kit formulations, reduce packaging complexity and optimize palletization to lower transportation inefficiencies. These operational adaptations underscore the need for coordinated supply chain resilience planning and the importance of establishing transparent communication channels with end users to manage expectations during periods of trade policy volatility.

Comprehensive segmentation insights that map product types, application demands, end-user profiles and sequencing technologies to strategic kit design and deployment

Detailed segmentation provides clarity on the distinct product configurations and user requirements that define the sequencing kits ecosystem. Product type distinctions separate library preparation kits, sequencing kits and template preparation kits, with library preparation further differentiating amplicon-focused kits, RNA sequencing optimized kits and whole genome library solutions. Sequencing kit varieties include nanopore-oriented chemistries alongside sequencing-by-synthesis formulations, and the nanopore category itself splits into biological nanopore reagents and solid-state implementations. Template preparation workflows capture both bridge PCR and emulsion PCR approaches, each with implications for throughput and application suitability.

Application-based segmentation frames how kits are tailored to specific analytical goals, ranging from exome and targeted sequencing use cases to transcriptome analyses and whole genome interrogation. Exome protocols vary between clinical-grade and research-focused implementations, while targeted strategies encompass hybridization-based enrichment as well as PCR-driven target selection. Transcriptome sequencing includes both bulk RNA and single-cell RNA methodologies, each driving distinct requirements for input handling and amplification fidelity. End-user segmentation emphasizes the different operational demands of academic research institutes, clinical diagnostic laboratories and pharmaceutical or biotechnology companies, and highlights nuance within these categories such as government research centers versus university laboratories, hospital diagnostic facilities versus independent labs, and the distinctions between startup biotechnology firms and established global pharmaceutical companies. Finally, sequencing technology segmentation differentiates core platforms including nanopore, sequencing by ligation and sequencing by synthesis, with further granularity between biological and solid-state nanopore implementations, which influence kit chemistry choices and workflow integration strategies.

Taken together, these segmentation lenses clarify how product design, regulatory readiness and service models must be aligned to the specific needs of applications and end users, enabling manufacturers and distributors to prioritize product roadmaps and technical support offerings that resonate with their target customer segments.

Regional strategic perspectives that reconcile distinct regulatory, infrastructure and procurement realities across Americas, Europe Middle East and Africa and Asia Pacific markets

Regional dynamics shape demand patterns, regulatory requirements and supply chain architectures for sequencing kits across three primary geographies. In the Americas, robust academic networks and a mature clinical diagnostics market drive demand for kits that emphasize regulatory compliance, reproducibility and integration with established instrument bases. Procurement processes are influenced by institutional purchasing cycles and the presence of domestic manufacturing capacity for key reagents, creating a context in which timely technical support and validated protocols are decisive purchasing criteria.

Across Europe, Middle East & Africa, diverse regulatory landscapes and heterogeneous research infrastructures create both challenges and opportunities for kit providers. Harmonization efforts and pan-regional clinical networks increase the appeal of kits with strong documentation, multilingual technical resources and adaptable workflows that can be validated locally. Additionally, emerging biotech hubs in several markets within this region are accelerating adoption of advanced sequencing approaches, prompting suppliers to offer flexible supply arrangements and localized training programs.

In the Asia-Pacific region, rapid expansion of genomic research capabilities and increasing clinical sequencing penetration favor kits that can scale across high-volume operations while remaining cost-effective and robust in varied laboratory settings. Local manufacturing initiatives and government-supported research programs further incentivize suppliers to establish regional presences, co-development partnerships and localized quality systems to meet regulatory expectations and expedite market entry. Collectively, regional considerations underscore the need for geographically informed product strategies and supply chain models that accommodate differing regulatory, infrastructural and commercial realities.

Key competitive dynamics and corporate strategies that determine success through portfolio integration, supply chain resilience and end to end solution offerings

Company strategies within the sequencing kits arena are increasingly defined by portfolio breadth, depth of technical support and the ability to offer integrated workflows that reduce barriers to adoption. Leading kit developers emphasize compatibility with multiple sequencing platforms while investing in formulation improvements that enhance shelf life and reduce protocol complexity. Strategic partnerships with instrument manufacturers, automation vendors and bioinformatics solution providers further extend value propositions by creating end-to-end solutions that address both wet-lab and data-driven needs.

In addition to product innovation, competitive differentiation arises from supply chain reliability and the capacity to deliver validated protocols and training at scale. Companies that maintain transparent quality systems, responsive technical service and clear documentation gain traction among diagnostics laboratories and large research consortia that prioritize reproducibility and regulatory readiness. Moreover, where companies pursue vertical integration-combining reagent production with consumable manufacturing and distribution-they can offer bundled solutions that simplify procurement and support lifecycle management. Finally, an emphasis on modular kit design and application-specific optimization enables firms to capture diverse use cases while minimizing the need for extensive inventory SKUs, supporting both operational efficiency and customer-focused customization.

Actionable strategic recommendations for manufacturers and providers to enhance resilience, broaden adoption and accelerate integration of sequencing kits into complex laboratory workflows

Industry leaders can take concrete actions to strengthen market position and respond to both technological and policy-driven shifts. First, prioritizing supply chain diversification and establishing dual-sourcing arrangements for critical reagents and consumables will reduce vulnerability to trade disruptions, while regional manufacturing investments can shorten lead times and enhance service responsiveness. Second, investing in modular kit architectures and standardized interfaces for automation platforms will broaden addressable customer segments and lower barriers to integration for high-throughput laboratories.

Third, engaging proactively with regulatory bodies and clinical stakeholders to develop validated, documentation-rich kit offerings will accelerate adoption in diagnostic settings and build trust among procurement decision-makers. Fourth, deepening collaboration with instrument and software partners to deliver verified end-to-end workflows will create compelling value propositions that go beyond single-product sales. Finally, cultivating robust post-sale support, including hands-on training, protocol optimization services and rapid technical escalation pathways, will increase customer retention and enable manufacturers to capture customer-driven product improvements through feedback loops that inform iterative innovation.

A robust mixed methodology combining primary stakeholder engagement, technical validation and supply chain analysis to produce practical and reliable insights for decision makers

This research synthesizes insights from a layered methodology that combines primary stakeholder engagement with rigorous secondary analysis and technical validation. Primary research included in-depth interviews with laboratory directors, procurement specialists, product managers and regulatory affairs professionals to capture first-hand perspectives on operational priorities, pain points and adoption drivers. These qualitative inputs were complemented by a comprehensive review of technical literature, regulatory guidance documents and product specification sheets to ensure accurate representation of kit chemistries, workflow dependencies and compliance considerations.

To augment qualitative findings, the analysis incorporated product portfolio mapping, patent landscape assessment and supply chain tracing to identify common manufacturing dependencies and distribution models. Technical validation was achieved through cross-referencing vendor protocol performance claims with independent experimental reports and user feedback, while expert panel reviews provided additional scrutiny of categorizations and strategic implications. Throughout the methodology, emphasis was placed on triangulation and transparency to ensure that conclusions reflect convergent evidence rather than single-source assertions, enabling practical recommendations that are grounded in operational realities.

Concluding perspectives that crystallize the strategic priorities for stakeholders to navigate innovation, regulation and supply chain complexity in sequencing kits

In sum, sequencing kits occupy a pivotal role in enabling high-quality genomic and transcriptomic assays, and their strategic importance is increasing as applications diversify and platform plurality expands. Manufacturers and distributors who align product design with application-specific needs, invest in supply chain resilience, and offer verifiable integration with automation and data workflows will be best positioned to meet the evolving expectations of research and clinical customers. Policy and trade developments underscore the need for flexible sourcing strategies and transparent communication to mitigate disruption risks.

Looking ahead, the most successful organizations will balance rapid innovation in kit chemistries and workflows with a relentless focus on reproducibility, regulatory alignment and post-sale support. By doing so, they can not only address current operational constraints but also enable laboratories to adopt more ambitious experimental designs that drive scientific and clinical advances. This conclusion highlights the strategic imperatives that should guide R&D prioritization, commercial planning and customer engagement across the sequencing kits ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of automated microfluidics and robotics in NGS kits for high-throughput clinical diagnostics
  • 5.2. Adoption of CRISPR-based target enrichment NGS kits to enhance rare variant detection sensitivity
  • 5.3. Expansion of single-cell sequencing NGS kits enabling simultaneous multiomic profiling at single-cell level
  • 5.4. Emergence of portable nanopore-based NGS kits facilitating real-time genomic surveillance in remote settings
  • 5.5. Development of cost-effective multiplexed NGS kits optimized for large-scale population genomic screening

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. NGS Kits Market, by Product Type

  • 8.1. Library Preparation Kits
    • 8.1.1. Amplicon Library Kits
    • 8.1.2. RNA-Seq Library Kits
    • 8.1.3. Whole Genome Library Kits
  • 8.2. Sequencing Kits
    • 8.2.1. Nanopore Sequencing Kits
      • 8.2.1.1. Biological Nanopore Kits
      • 8.2.1.2. Solid-State Nanopore Kits
    • 8.2.2. Sequencing By Synthesis Kits
  • 8.3. Template Preparation Kits
    • 8.3.1. Bridge PCR Kits
    • 8.3.2. Emulsion PCR Kits

9. NGS Kits Market, by Application

  • 9.1. Exome Sequencing
    • 9.1.1. Clinical Exome Sequencing
    • 9.1.2. Research Exome Sequencing
  • 9.2. Targeted Sequencing
    • 9.2.1. Hybridization Based Targeted Sequencing
    • 9.2.2. PCR Based Targeted Sequencing
  • 9.3. Transcriptome Sequencing
    • 9.3.1. Bulk RNA Sequencing
    • 9.3.2. Single Cell RNA Sequencing
  • 9.4. Whole Genome Sequencing

10. NGS Kits Market, by End User

  • 10.1. Academic Research Institute
    • 10.1.1. Government Research Centers
    • 10.1.2. University Laboratories
  • 10.2. Clinical Diagnostic Laboratories
    • 10.2.1. Hospital Diagnostic Laboratories
    • 10.2.2. Independent Diagnostic Laboratories
  • 10.3. Pharmaceutical Biotechnology Companies
    • 10.3.1. Biotechnology Startups
    • 10.3.2. Global Pharmaceutical Companies

11. NGS Kits Market, by Sequencing Technology

  • 11.1. Nanopore Sequencing
    • 11.1.1. Biological Nanopore
    • 11.1.2. Solid-State Nanopore
  • 11.2. Sequencing By Ligation
  • 11.3. Sequencing By Synthesis

12. NGS Kits Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. NGS Kits Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. NGS Kits Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Illumina, Inc.
    • 15.3.2. Thermo Fisher Scientific Inc.
    • 15.3.3. Roche Holding AG
    • 15.3.4. Danaher Corporation
    • 15.3.5. MGI Tech Co., Ltd.
    • 15.3.6. Agilent Technologies, Inc.
    • 15.3.7. PerkinElmer, Inc.
    • 15.3.8. Takara Bio Inc.
    • 15.3.9. Oxford Nanopore Technologies plc
    • 15.3.10. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NGS KITS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS NGS KITS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL NGS KITS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL NGS KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NGS KITS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. NGS KITS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NGS KITS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NGS KITS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NGS KITS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NGS KITS MARKET SIZE, BY AMPLICON LIBRARY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NGS KITS MARKET SIZE, BY RNA-SEQ LIBRARY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME LIBRARY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NGS KITS MARKET SIZE, BY BRIDGE PCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NGS KITS MARKET SIZE, BY EMULSION PCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NGS KITS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NGS KITS MARKET SIZE, BY UNIVERSITY LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NGS KITS MARKET SIZE, BY HOSPITAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NGS KITS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NGS KITS MARKET SIZE, BY BIOTECHNOLOGY STARTUPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL NGS KITS MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL NGS KITS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL NGS KITS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS NGS KITS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS NGS KITS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS NGS KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS NGS KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS NGS KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS NGS KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA NGS KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA NGS KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA NGS KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 312. NORTH AMERICA NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. NORTH AMERICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 316. NORTH AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA NGS KITS MARKET SIZE, BY SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING KITS, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA NGS K